• Your shopping cart is empty!

PDF Preview

CLSI POCT14

Point-of-Care Monitoring of Anticoagulation Therapy; Approved Guideline, POCT14AE

Clinical and Laboratory Standards Institute, 07/27/2020

Publisher: CLSI

File Format: PDF

$90.00$180.00


Published:27/07/2020

Pages:68

File Size:1 file , 6.8 MB

Note:This product is unavailable in Russia, Belarus

This guideline provides recommendations to users and manufacturers of point-of-care coagulation testing devices for monitoring heparin and vitamin K antagonist therapy and for the evaluation of hemostasis, as well as to ensure reliable results comparable with those obtained by routine medical laboratory testing.

More CLSI standard pdf

CLSI MM14-A2 (R2018)

CLSI MM14-A2 (R2018)

Design of Molecular Proficiency Testing/External Quality Assessment; Approved Guideline - Second Edition, MM14A2E

$90.00 $180.00

CLSI VET01-A4 and VET01-S2

CLSI VET01-A4 and VET01-S2

Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacterial Isolated from Animals; Approved Standard-Fourth Edition and Supplement, VET01A4E and VET01S2E

$144.00 $289.01

CLSI NBS06-A

CLSI NBS06-A

Newborn Blood Spot Screening for Severe Combined Immunodeficiency by Measurement of T-cell Receptor Excision Circles; Approved Guideline, NBS06AE

$90.00 $180.00

CLSI QMS02-A6 (R2018)

CLSI QMS02-A6 (R2018)

Quality Management System: Development and Management of Laboratory Documents; Approved Guideline-Sixth Edition, QMS02A6E

$90.00 $180.00